-
Symbol
-
LPTX on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock, par value $0.001 per share
-
Latest Disclosed Ownership
-
1.22M shares
-
Security Ownership
-
0%
BeiGene, Ltd. ownership in LEAP THERAPEUTICS, INC. Common Stock, par value $0.001 per share (LPTX)
2024-10-31 - BeiGene, Ltd. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.22M shares of LEAP THERAPEUTICS, INC. Common Stock, par value $0.001 per share (LPTX).
This represents 0% percent ownership of the company.